(Q36422889)

14 August 2017

1 reference

title

Human African trypanosomiasis-neurological aspects (English)

1 reference

14 August 2017

0 references

African trypanosomiasis

0 references

(RS)-eflornithine

1 reference

ChEBI release 2020-05-28

Peter G E Kennedy

1

1 reference

14 August 2017

20 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

253

1 reference

14 August 2017

4

1 reference

14 August 2017

411-416

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-006-0093-3

14 August 2017

0 references

cites work

Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis

1 reference

12 December 2020

Nitric oxide and cytokine synthesis in human African trypanosomiasis

1 reference

12 December 2020

Sleeping sickness: new drugs from old? [corrected].

1 reference

12 December 2020

Comparison of different DNA preparation protocols for PCR diagnosis of Human African Trypanosomosis in Côte d'Ivoire

1 reference

12 December 2020

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

1 reference

12 December 2020

Human African trypanosomiasis of the CNS: current issues and challenges

1 reference

12 December 2020

The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis.

1 reference

12 December 2020

The treatment of human African trypanosomiasis

1 reference

12 December 2020

The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis

1 reference

12 December 2020

A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei

1 reference

12 December 2020

Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis

1 reference

12 December 2020

Sleeping sickness in Europeans: a review of 109 cases

1 reference

12 December 2020

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

1 reference

12 December 2020

Options for field diagnosis of human african trypanosomiasis

1 reference

12 December 2020

Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment.

1 reference

12 December 2020

Antigenic variation and the African trypanosome genome

1 reference

12 December 2020

Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice

1 reference

12 December 2020

Current situation of African trypanosomiasis

1 reference

12 December 2020

IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test.

1 reference

12 December 2020

Eflornithine for the treatment of human African trypanosomiasis

1 reference

12 December 2020

Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee

1 reference

12 December 2020

Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness

1 reference

12 December 2020

10.1007/S00415-006-0093-3

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16541214